Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants

ClinicalTrials.gov ID: NCT05865041

Public ClinicalTrials.gov record NCT05865041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 7:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel Group Treatment, Phase 2a, Double-blind, Two-arm Study to Investigate the Efficacy and Safety of Farudodstat Tablets Compared With Its Placebo in Male or Female Alopecia Areata Participants Aged 18 Years and Older With 30% or Greater Scalp Hair Loss

Study identification

NCT ID: NCT05865041
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: ASLAN Pharmaceuticals; Other
Enrollment: 60 participants

Conditions and interventions

Conditions

Alopecia Areata

Interventions

Farudodstat Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 13, 2023
Primary completion: Sep 11, 2024
Completion: Oct 30, 2024
Last update posted: Dec 17, 2023

2023 – 2024

United States locations

U.S. sites: 19
U.S. states: 14
U.S. cities: 19

Facility	City	State	ZIP	Site status
1 Site	Birmingham	Alabama	35205	Recruiting
1 Site	Fountain Valley	California	92708	Recruiting
1 Site	Santa Ana	California	92701	Recruiting
1 Site	New Haven	Connecticut	06519	Recruiting
1 Site	Washington D.C.	District of Columbia	20037	Recruiting
1 Site	Coral Gables	Florida	33134	Recruiting
1 Site	Indianapolis	Indiana	46250	Recruiting
1 Site	Louisville	Kentucky	40241	Recruiting
1 Site	Brighton	Massachusetts	02135	Recruiting
1 Site	Minneapolis	Minnesota	55455	Recruiting
1 Site	New Brighton	Minnesota	55112	Recruiting
1 Site	Saint Joseph	Missouri	64506	Recruiting
1 Site	Omaha	Nebraska	68114	Recruiting
1 Site	Cleveland	Ohio	44195	Recruiting
1 Site	Columbus	Ohio	43215	Recruiting
1 Site	Nashville	Tennessee	37215	Recruiting
1 Site	Pflugerville	Texas	78660	Recruiting
2 Sites	San Antonio	Texas	78218	Recruiting
1 Site	Webster	Texas	77598	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05865041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 17, 2023 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05865041 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →